Vision Financial Markets
SLS icon

Vision Financial Markets’s SELLAS Life Sciences SLS Stock Holding History

Vision Financial Markets’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$702K Buy
57,000
+47,200
+482% +$591K 0.53% 29
2026
Q2 		$145K Sell
9,800
-294,600
-97% -$2.03M 0.13% 90
2026
Q1 		$1.29M Buy
+304,400
New +$1.36M 1.26% 15

Other funds holding SLS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Vision Financial Markets's SLS Position: Q3 2026 in Review

Vision Financial Markets increased its SELLAS Life Sciences (SLS) stake by 482% in Q3 2026, buying an estimated $591K and bringing the position to 57,000 shares worth $702K. The position accounts for 0.53% of the portfolio, ranked #29.

Vision Financial Markets first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.29M in Q1 2026. 92 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Vision Financial Markets held 57,000 shares of SELLAS Life Sciences worth $702K as of Q3 2026.
  • Vision Financial Markets bought 47,200 SELLAS Life Sciences shares in Q3 2026, an estimated $591K.
  • SELLAS Life Sciences made up 0.53% of Vision Financial Markets's portfolio in Q3 2026, its #29 holding.
  • Vision Financial Markets first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • Vision Financial Markets's SELLAS Life Sciences position peaked at $1.29M in Q1 2026.
  • 92 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Vision Financial Markets's 13F filing for Q3 2026, filed 22 Oct 2026.